clinical trial · NCT00649181
Fasting Study of Metolazone Tablets 5 mg and Zaroloxyn® Tablets 5 mg
HealthyMetolazone Tablets 5 mgZaroloxyn® Tablets 5 mg
brief summary
The objective of this study was to investigate the bioequivalence of Mylan metolazone 5 mg tablets to Celltech Zaroxolyn® 5 mg tablets following a single, oral 10 mg (2 x 5 mg) dose administration under fasting conditions.
started
Oct 1, 2003
primary completion
Nov 1, 2003
completion
Nov 1, 2003
last updated
Apr 24, 2024
official title
Single-Dose Fasting In Vivo Bioequivalence Study of Metolazone Tablets (5 mg; Mylan) and Zaroloxyn® Tablets (5 mg; Celltech) in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol